Literature DB >> 3019268

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims.

J J Mann, M Stanley, P A McBride, B S McEwen.   

Abstract

A statistically significant 28% increase in the mean (+/- SD) number of serotonin2 receptors (127.8 +/- 13.4 vs 99.6 +/- 11.1 fmol/mg of protein) and a 73% increase in beta-adrenergic receptor binding (14.5 +/- 1.5 vs 8.4 +/- 1.5 fmol/mg) was found in the frontal cortices of violent suicide victims compared with matched controls. No significant differences were found in the number of serotonin1 binding sites (109.5 +/- 13.4 vs 99.9 +/- 8.8 fmol/mg). We have previously reported a reduced density of presynaptic tritiated imipramine binding sites on serotonergic nerve terminals in the frontal cortices of suicide victims. These data support the hypothesis that suicide completed by violent methods is associated with reduced presynaptic serotonergic activity that has generated compensatory upregulation of the postsynaptic serotonin2 receptor sites. The increase observed in beta-adrenergic binding suggests that there may also be a concomitant reduction in presynaptic noradrenergic activity associated with suicide. If antidepressant pharmacotherapies specifically downregulate cortical beta-adrenergic and/or serotonin2 receptors in depressed subjects, as has been demonstrated in animal studies, and since these effects would be in the opposite direction of the receptor changes found in suicide victims, they may account for the therapeutic action of antidepressants on suicidal behavior and depressive disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019268     DOI: 10.1001/archpsyc.1986.01800100048007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  54 in total

Review 1.  The interpersonal theory of suicide.

Authors:  Kimberly A Van Orden; Tracy K Witte; Kelly C Cukrowicz; Scott R Braithwaite; Edward A Selby; Thomas E Joiner
Journal:  Psychol Rev       Date:  2010-04       Impact factor: 8.934

Review 2.  Neurobiology of chronic mild stress: parallels to major depression.

Authors:  Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2012-07-07       Impact factor: 8.989

3.  Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment.

Authors:  F De Paermentier; S C Cheetham; M R Crompton; C L Katona; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  The effect of sympathetic antagonists on the antidepressant action of alprazolam.

Authors:  Ra Al-Tubuly; Sm Aburawi; Ea Alghzewi; Zm Gorash; S Errwami
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

5.  Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation.

Authors:  A S Eison; F D Yocca; G Gianutsos
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Neurobiology of suicidal behavior. An integration of biological and clinical findings.

Authors:  Juan J Carballo; Chibuikem P Akamnonu; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2008

7.  [123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.

Authors:  Oliver Pogarell; Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Hans-Jürgen Möller; Ulrich Hegerl; Klaus Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

Review 8.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 9.  Can drugs cause depression? A review of the evidence.

Authors:  S B Patten; E J Love
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

10.  Serotonin2A receptor binding potential in people with aggressive and violent behaviour.

Authors:  Jeffrey H Meyer; Alan A Wilson; Pablo Rusjan; Michael Clark; Sylvain Houle; Scott Woodside; John Arrowood; Krystle Martin; Michael Colleton
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.